Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.560, 2008-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sunitinib cost effective for renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 532, 2007-01 ,pp. :
Access to resources
Recommend
Sunitinib soars ahead in renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 580, 2009-01 ,pp. :
Sunitinib surpasses standard therapy for metastatic renal cancer
Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. :
First-line sunitinib cost-effective alternative to interferon-α in renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 561, 2008-01 ,pp. :